StockData
Avalyn Pharma Inc. logo

Avalyn Pharma Inc. (AVLN) stock

AVLNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$27.92−1.84 (-6.18%)

Close on Nov 17, 2026Market cap $1.24BP/E –Yield –

Avalyn Pharma cash

Cash and short-term investments held at the end of each period.

Avalyn Pharma's cash was $352.43M at Jun 30, 2026. For fiscal 2025 it was $138.36M, up 477.6% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$138.36M+477.6%
FY2024Dec 31, 2024$23.96M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$352.43M+1123.7%
Q1 FY2026Mar 31, 2026$123.13M+414.0%
Q4 FY2025Dec 31, 2025$138.36M–
Q2 FY2025Jun 30, 2025$61.30M–
Q1 FY2025Mar 31, 2025$28.80M–
Q4 FY2024Dec 31, 2024$23.96M–

More Avalyn Pharma figures

See a number that looks wrong?